Systemic antivenom and skin necrosis after green pit viper bites

References

• Viravan C, Looareesuwan S, Kosakarn W, Wuthiekanun V, McCarthy CJ, Stimson AF, Bunnag D, Harinasuta T, Warrell DA. A national hospital-based survey of snakes responsible for bites in Thailand. Trans R Soc Trop Med Hyg 1992; 86: 100–106
   PubMed Web of Science ®Google Scholar
• Mahasandana S, Rungruxsirivorn Y, Chantarangkul V. Clinical manifestations of bleeding following Russell's viper and green pit viper bites in adults. Southeast Asian J Trop Med Public Health 1980; 11: 285–293
   PubMedGoogle Scholar
• Meemano K, Pochanugool C, Limthongkul S. Incidence of snakebites at Chulalongkorn hospital. In: eds. Progress in Venom and Toxin Research, P Gopalakrishnakone, CK Tan. National University of Singapore, Singapore 1987; 36–40
   Google Scholar
• Mahasandana S, Jintakune P. The species of green pit viper in Bangkok. Southeast Asian J Trop Med Public Health 1990; 21: 225–230
   PubMedGoogle Scholar
• Mitrakul C. Effects of green pit viper (Trimeresurus erythrurus and T. popeorum) venoms on blood coagulation, platelets and the fibrinolytic enzyme systems: studies in vivo and in vitro. Am J Clin Pathol 1973; 60: 654–662
   PubMed Web of Science ®Google Scholar
• Rojnuckarin P, Mahasandana S, Intragumthornchai T, Sutcharitchan P, Swasdikul D. Prognostic factors of green pit viper bites. Am J Trop Med Hyg 1998; 58: 22–25
   PubMed Web of Science ®Google Scholar
• Warrell DA, Looareesuwan S, Theakston RD, Phillips RE, Chanthavanich P, Viravan C, Supanaranond W, Karbwang J, Ho M, Hutton RA, Vejcho A. Randomized comparative trial of three monospecific antivenoms for bites by the Malayan pit viper (Calloselasma rhodostoma) in southern Thailand: clinical and laboratory correlations. Am J Trop Med Hyg 1986; 35: 1235–1247
   PubMed Web of Science ®Google Scholar
• Dart RC, Seifert SA, Boyer LV, Clark RF, Hall E, McKinney P, McNally J, Kitchens CS, Curry SC, Bogdan GM, Ward SB, Porter RS. A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med 2001; 161: 2030–2036
   PubMed Web of Science ®Google Scholar
• Pardal PP, Souza SM, Monteiro MR, Fan HW, Cardoso JL, Franca FO, Tomy SC, Sano-Martins IS, de Sousa-e-Silva MC, Colombini M, Kodera NF, Moura-da-Silva AM, Cardoso DF, Velarde DT, Kamiguti AS, Theakston RD, Warrell DA. Clinical trial of two antivenoms for the treatment of Bothrops and Lachesis bites in the Northeastern Amazon region of Brazil. Trans R Soc Trop Med Hyg 2004; 98: 28–42
   PubMed Web of Science ®Google Scholar
• Smalligan R, Cole J, Brito N, Laing GD, Mertz BL, Manock S, Maudlin J, Quist B, Holland G, Nelson S, Lalloo DG, Rivadeneira G, Barragan ME, Dolley D, Eddleston M, Warrell DA, Theakston RD. Crotaline snake bite in the Ecuadorian Amazon: randomised double blind comparative trial of three South American polyspecific antivenoms. Br Med J 2004; 329: 1129
   PubMed Web of Science ®Google Scholar
• Karlson-Stiber C, Persson H. Antivenom treatment in Vipera berus envenoming--report of 30 cases. J Intern Med 1994; 235: 57–61
   PubMed Web of Science ®Google Scholar
• Ariaratnam CA, Sjostrom L, Raziek Z, Kularatne SA, Arachchi RW, Sheriff MH, Theakston RD, Warrell DA. An open, randomized comparative trial of two antivenoms for the treatment of envenoming by Sri Lankan Russell's viper (Daboia russelii russelii). Trans R Soc Trop Med Hyg 2001; 95: 74–80
   PubMed Web of Science ®Google Scholar
• Sellahewa KH, Gunawardena G, Kumararatne MP. Efficacy of antivenom in the treatment of severe local envenomation by the hump-nosed viper (Hypnale hypnale). Am J Trop Med Hyg 1995; 53: 260–262
   PubMed Web of Science ®Google Scholar
• Rojnuckarin P, Chanthawibun W, Noiphrom J, Pakmanee N, Intragumtornchai T. A randomized, double blind, placebo-controlled trial of antivenom for local effects of green pit viper bites. Trans R Soc Trop Med Hyg 2006; 100: 879–884
   PubMed Web of Science ®Google Scholar
• Hougie C. Whole blood coagulation time test and clot observation. In: ed. Hematology, WJ Williams. Mc-Graw-Hill Publishing Co, New York 1990; 1765
   Google Scholar
• Gutierrez JM, Rucavado A, Escalante T, Diaz C. Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage. Toxicon 2005; 45: 997–1011
   PubMed Web of Science ®Google Scholar
• Rucavado A, Nunez J, Gutierrez JM. Blister formation and skin damage induced by BaP1, a haemorrhagic metalloproteinase from the venom of the snake Bothrops asper. Int J Exp Pathol 1998; 79: 245–254
   PubMed Web of Science ®Google Scholar
• Laing GD, Clissa PB, Theakston RD, Moura-da-Silva AM, Taylor MJ. Inflammatory pathogenesis of snake venom metalloproteinase-induced skin necrosis. Eur J Immunol 2003; 33: 3458–3463
   PubMed Web of Science ®Google Scholar
• Rucavado A, Escalante T, Franceschi A, Chaves F, Leon G, Cury Y, Ovadia M, Gutierrez JM. Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA. Am J Trop Med Hyg 2000; 63: 313–319
   PubMed Web of Science ®Google Scholar
• Perales J, Neves-Ferreira AG, Valente RH, Domont GB. Natural inhibitors of snake venom hemorrhagic metalloproteinases. Toxicon 2005; 45: 1013–1020
   Google Scholar
• Laing GD, Moura-da-Silva AM. Jararhagin and its multiple effects on hemostasis. Toxicon 2005; 45: 987–996
   PubMed Web of Science ®Google Scholar